Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 21;9(2):72.
doi: 10.3390/pathogens9020072.

Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection

Affiliations

Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection

Laura Veschetti et al. Pathogens. .

Abstract

Achromobacter xylosoxidans can cause chronic infections in the lungs of patients with cystic fibrosis (CF) by adapting to the specific environment. The study of longitudinal isolates allows to investigate its within-host evolution to unravel the adaptive mechanisms contributing to successful colonization. In this study, four clinical isolates longitudinally collected from two chronically infected patients underwent whole genome sequencing, de novo assembly and sequence analysis. Phenotypic assays were also performed. The isolates coming from one of the patients (patient A) presented a greater number of genetic variants, diverse integrative and conjugative elements, and different protease secretion. In the first of these isolates (strain A1), we also found a large deletion in the mutS gene, involved in DNA mismatch repair (MMR). In contrast, isolates from patient B showed a lower number of variants, only one integrative and mobilizable element, no phenotypic changes, and no mutations in the MMR system. These results suggest that in the two patients the establishment of a chronic infection was mediated by different adaptive mechanisms. While the strains isolated from patient B showed a longitudinal microevolution, strain A1 can be clearly classified as a hypermutator, confirming the occurrence and importance of this adaptive mechanism in A. xylosoxidans infection.

Keywords: bacterial evolution; clonal diversification; comparative genomics; lung infection; opportunistic pathogen.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Growth rate (A), biofilm formation (B) and protease activity (C) of A. xylosoxidans isolates. Growth rate was calculated from 24 h growth curves in LB medium (A). Adhesion was measured by crystal violet staining of surface-attached bacteria divided by A600 of non-attached bacteria (B). Protease activity was measured in culture supernatant by azocasein assay. Protease activity is expressed as enzymatic units per ml (C). Each value represents the mean ± SEM of three experiments. Statistical analysis was performed by t test, ** p < 0.01.

Similar articles

Cited by

References

    1. Ciofu O., Hansen C.R., Hoiby N. Respiratory bacterial infections in cystic fibrosis. Curr. Opin. Pulm. Med. 2013;19:251–258. doi: 10.1097/MCP.0b013e32835f1afc. - DOI - PubMed
    1. Hansen C.R., Pressler T., Nielsen K.G., Jensen P.Ø., Bjarnsholt T., Høiby N. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 2010;9:51–58. doi: 10.1016/j.jcf.2009.10.005. - DOI - PubMed
    1. Ridderberg W., Wang M., Norskov-Lauritsen N. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. J. Clin. Microbiol. 2012;50:2688–2694. doi: 10.1128/JCM.00728-12. - DOI - PMC - PubMed
    1. Hansen C.R., Pressler T., Ridderberg W., Johansen H.K., Skov M. Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to-patient contact. J. Cyst. Fibros. 2013;12:609–615. doi: 10.1016/j.jcf.2013.05.004. - DOI - PubMed
    1. Lambiase A., Catania M.R., del Pezzo M., Rossano F., Terlizzi V., Sepe A., Raia V. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 2011;30:973–980. doi: 10.1007/s10096-011-1182-5. - DOI - PMC - PubMed

LinkOut - more resources